Want to join the conversation?
Julien Dumoulin-Smith with UBS asks about recovery in terms of capital vs. O&M. $DUK said that whether it's capital or O&M it is a cost that's incurred. Conceptually, the company views it as a cost incurred for an extended period that therefore requires financing and recovery in a subsequent rate proceeding.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?